Table 2.

Third level FunCat Enrichment Analysis^* of genes differentially expressed.

FunCat ID	Category	15 min		30 min		1 h		3 h
		Down hits (p-value)	Up hits (p-value)	Down hits (p-value)	Up hits (p-value)	Down hits (p-value)	Up hits (p-value)	Down hits (p-value)	Up hits (p-value)
11.06.01	rRNA modification	2 (4.43 × 10−3)		2 (1.65 × 10−2)
20.01.21	RNA transport	3 (7.44 × 10−3)		3 (4.51 × 10−2)
14.13.04	Lysosomal and vacuolar protein degradation	2 (2.22 × 10−2)				3 (1.27 × 10−2)
01.03.16	Polynucleotide degradation	3 (2.70 × 10−2)
16.03.03	RNA binding	5 (3.40 × 10−2)		8 (2.67 × 10−2)				8 (3.26 × 10−3)
32.07.07	Oxygen and radical detoxification		3 (6.28 × 10−3)
12.04.03	Translation termination		1 (4.10 × 10−2)
30.01.11	Ligand-dependent nuclear receptors		1 (4.10 × 10−2)
16.21.08	Fe/S binding			5 (3.02 × 10−5)		5 (4.29 × 10−6)
02.11.05	Accessory proteins of electron transport and membrane-associated energy conservation			5 (2.45 × 10−4)		6 (2.97 × 10−6)
11.02.01	rRNA synthesis			5 (1.29 × 10−3)				5 (2.47 × 10−4)
02.13.03	Aerobic respiration			5 (3.54 × 10−3)		8 (1.24 × 10−5)
02.13.01	Anaerobic respiration			2 (4.64 × 10−3)		2 (5.34 × 10−3)
16.21.07	NAD/NADP binding			7 (7.91 × 10−3)
20.01.15	Electron transport			9 (1.25 × 10−2)		15 (8.57 × 10−6)			6 (4.76 × 10−2)
01.03.01	Purin nucleotide/nucleoside/nucleobase metabolism			5 (1.83 × 10−2)
01.20.01	Metabolism of primary metabolic sugar derivatives			2 (3.42 × 10−2)
16.21.05	FAD/FMN binding			4 (4.54 × 10−2)		5 (1.46 × 10−2)
11.04.03	mRNA processing (splicing, 5′-, 3′-end processing)				13 (4.56 × 10−4)		17 (3.67 × 10−4)
11.04.02	tRNA processing				4 (2.05 × 10−2)		7 (9.41 × 10−4)	3 (1.29 × 10−2)
01.03.04	Pyrimidine nucleotide/nucleoside/nucleobase metabolism				4 (4.19 × 10−2)
16.01.01	Receptor binding				2 (4.28 × 10−2)
10.01.03	DNA synthesis and replication				6 (4.72 × 10−2)		10 (6.14 × 10−3)
01.01.05	Metabolism of urea cycle, creatine and polyamines					4 (1.82 × 10−3)
34.01.01	Homeostasis of cations					8 (1.17 × 10−2)
20.01.01	Ion transport					8 (1.56 × 10−2)
01.20.36	Non-ribosomal peptide synthesis					2 (2.58 × 10−2)
02.45.15	Energy generation (e.g. ATP synthase)					2 (3.08 × 10−2)
16.03.01	DNA binding					1 (4.23 × 10−2)	22 (3.16 × 10−3)
01.01.11	Metabolism of the pyruvate family (alanine, isoleucine, leucine, valine) and D-alanine					3 (4.46 × 10−2)
10.01.05	DNA recombination and DNA repair						17 (2.18 × 10−3)
40.10.02	Apoptosis (type I programmed cell death)						10 (3.40 × 10−3)
01.05.02	Sugar, glucoside, polyol and carboxylate metabolism						1 (4.87 × 10−3)
11.06.02	tRNA modification						5 (6.32 × 10−3)
14.07.07	Modification by ubiquitin-related proteins						5 (6.94 × 10−3)
10.01.02	DNA topology						7 (7.87 × 10−3)
01.05.03	Polysaccharide metabolism						1 (2.25 × 10−2)
32.01.09	DNA damage response						8 (2.51 × 10−2)
10.03.04	Nuclear and chromosomal cycle						7 (3.21 × 10−2)
20.09.18	Cellular import						5 (4.21 × 10−2)
16.19.03	ATP binding						24 (4.40 × 10−2)	12 (3.04 × 10−3)
01.20.31	Metabolism of secondary products derived from L-lysine, L-arginine and L-histidine						2 (4.48 × 10−2)
14.13.01	Cytoplasmic and nuclear protein degradation						12 (4.60 × 10−2)
11.04.01	rRNA processing							6 (4.11 × 10−3)
01.01.09	Metabolism of the cysteine – aromatic group							5 (2.92 × 10−2)
01.20.15	Metabolism of derivatives of dehydroquinic acid, shikimic acid and chorismic acid							2 (4.25 × 10−2)
20.03.22	Transport ATPases							3 (4.74 × 10−2)
32.07.01	Detoxification involving cytochrome P450								3 (2.18 × 10−2)
34.11.01	Photoperception and response								2 (2.34 × 10−2)
01.25.09	Extracellular lignin degradation								1 (3.25 × 10−2)
01.25.03	Extracellular protein degradation								1 (4.05 × 10−2)

^*p-value cutoff for enrichment analysis 0.05